CN Stock MarketDetailed Quotes

Shaanxi Kanghui Pharmaceutical (603139)

Watchlist
  • 21.40
  • +0.17+0.80%
Market Closed Jan 16 15:00 CST
2.14BMarket Cap-11.62P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Shaanxi Kanghui Pharmaceutical (603139) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Pharmaceutical manufacturing150.21M60.68%
Pharmaceutical circulation91.07M36.79%
Other business6.26M2.53%

By Industry

Currency:CNY
2024/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing278.48M49.58%
Pharmaceutical circulation265.93M47.35%
Other business17.23M3.07%

By Country/Region

Currency:CNY
2025/H1
Stock NameRevenueRatio
China247.53M100.00%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.85%
Sample Name
Sample Code
 +16.38%
Sample Name
Sample Code
 +13.45%
4
BIDU-SW
09888
+5.97%
5
JD HEALTH
06618
+5.25%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.85%
Sample Name
Sample Code
 +3.48%
Sample Name
Sample Code
 +2.24%
4
Broadcom
AVGO
+1.11%
5
Microsoft
MSFT
+1.00%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -